{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:14:45Z","timestamp":1791342885017,"version":"4.3.1"},"reference-count":40,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>Historically, many children and adolescents with sickle cell disease (SCD) were underweight. Treatment advances like hydroxyurea have been associated with improved growth. We hypothesized that increased hemoglobin (Hb) levels would be associated with increased weight status of children with SCD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Investigators at 6 institutions conducted a retrospective chart review of all patients aged 2 to 19 years of age for the calendar years 2007\u20132009. Height, weight, baseline Hb levels, demographic information, and select comorbidities were recorded from the most recent clinic visit. Overweight and obesity were defined as \u226585th and \u226595th BMI percentiles for age and gender, respectively, and underweight was defined as &amp;lt;5th BMI percentile.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Data were collected on 675 children and adolescents in 3 New England states. In this sample, 22.4% were overweight or obese, whereas only 6.7% were underweight. Overweight or obese status was associated with sickle genotypes other than Hb SS or Hb S\u03b20 disease, and were associated with higher baseline Hb levels. Underweight individuals were more likely to be male, older, and have had at least 1 SCD-related complication. After adjusting for demographic factors, any SCD-related complication, SCD-directed treatments, and obesity-related conditions, there was a 36% increased odds of overweight\/obesity for each 1 g\/dL increase in baseline Hb levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Nearly one-quarter of children and adolescents with SCD in New England are overweight or obese. Longitudinal studies are needed to determine the impact of elevated BMI on the morbidity and mortality of both children and adults with SCD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2012-2225","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T09:09:40Z","timestamp":1362474580000},"page":"e1168-e1173","source":"Crossref","is-referenced-by-count":43,"title":["Weight Status of Children With Sickle Cell Disease"],"prefix":"10.1542","volume":"131","author":[{"given":"Anjulika","family":"Chawla","sequence":"first","affiliation":[{"name":"Hasbro Children\u2019s Hospital, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa G.","family":"Sprinz","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Welch","sequence":"additional","affiliation":[{"name":"Hasbro Children\u2019s Hospital, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Heeney","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Boston, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Usmani","sequence":"additional","affiliation":[{"name":"University of Massachusetts Memorial, Worcester, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Pashankar","sequence":"additional","affiliation":[{"name":"Yale\/New Haven, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"issue":"4","key":"2021120903270615200_B1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mrdd.20124","article-title":"National evaluation of US newborn screening system components.","volume":"12","author":"Therrell","year":"2006","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"4","key":"2021120903270615200_B2","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the US.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"13","key":"2021120903270615200_B3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease.","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120903270615200_B4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198407053110102","article-title":"Influence of sickle hemoglobinopathies on growth and development.","volume":"311","author":"Platt","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120903270615200_B5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/adc.82.3.204","article-title":"Height and weight reference curves for homozygous sickle cell disease.","volume":"82","author":"Thomas","year":"2000","journal-title":"Arch Dis Child"},{"issue":"1","key":"2021120903270615200_B6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3476(00)90053-2","article-title":"Total and resting energy expenditure in children with sickle cell disease.","volume":"136","author":"Barden","year":"2000","journal-title":"J Pediatr"},{"key":"2021120903270615200_B7"},{"issue":"2","key":"2021120903270615200_B8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2005.02.030","article-title":"Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.","volume":"147","author":"Wang","year":"2005","journal-title":"J Pediatr"},{"issue":"2","key":"2021120903270615200_B9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mpd.2002.121383","article-title":"Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study.","volume":"140","author":"Wang","year":"2002","journal-title":"J Pediatr"},{"key":"2021120903270615200_B10"},{"issue":"4","key":"2021120903270615200_B11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/08880010902896882","article-title":"Growth status in children and adolescents with sickle cell disease.","volume":"26","author":"Mitchell","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"2021120903270615200_B12"},{"issue":"5","key":"2021120903270615200_B13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010.","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"2021120903270615200_B14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/epirev\/mxm007","article-title":"The obesity epidemic in the United States\u2014gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis.","volume":"29","author":"Wang","year":"2007","journal-title":"Epidemiol Rev"},{"issue":"2","key":"2021120903270615200_B15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","article-title":"Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia.","volume":"102","author":"Pegelow","year":"1997","journal-title":"Am J Med"},{"issue":"1","key":"2021120903270615200_B16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000046529","article-title":"Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.","volume":"105","author":"Adekile","year":"2001","journal-title":"Acta Haematol"},{"key":"2021120903270615200_B17","unstructured":"Centers for Disease Control and Prevention. 2000 CDC Clinical Growth Charts for the United States. Available at: www.cdc.gov\/growthcharts. Accessed August 5, 2010"},{"issue":"4","key":"2021120903270615200_B18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ppul.21370","article-title":"Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades.","volume":"46","author":"Bhattacharjee","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2021120903270615200_B19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.prrv.2006.08.003","article-title":"Obesity and obstructive sleep apnea in children.","volume":"7","author":"Tauman","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"2021120903270615200_B20"},{"issue":"1","key":"2021120903270615200_B21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.HYP.0000151325.83008.b4","article-title":"Obesity-associated hypertension: new insights into mechanisms.","volume":"45","author":"Rahmouni","year":"2005","journal-title":"Hypertension"},{"key":"2021120903270615200_B22"},{"issue":"9778","key":"2021120903270615200_B23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"2021120903270615200_B24"},{"issue":"26","key":"2021120903270615200_B25","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120903270615200_B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120903270615200_B27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcl.2008.02.003","article-title":"Hydroxyurea for children with sickle cell disease.","volume":"55","author":"Heeney","year":"2008","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2021120903270615200_B28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"issue":"5 pt 1","key":"2021120903270615200_B29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1203\/pdr.0b013e318045bdca","article-title":"Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease.","volume":"61","author":"Zemel","year":"2007","journal-title":"Pediatr Res"},{"issue":"4","key":"2021120903270615200_B30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pbc.22137","article-title":"Growth patterns in children with sickle cell anemia during puberty.","volume":"53","author":"Rhodes","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"2021120903270615200_B31","first-page":"355","article-title":"Growth status of children with sickle-cell anemia.","volume":"102","author":"Whitten","year":"1961","journal-title":"Am J Dis Child"},{"issue":"5","key":"2021120903270615200_B32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/adc.71.5.404","article-title":"Delayed adolescent growth in homozygous sickle cell disease.","volume":"71","author":"Singhal","year":"1994","journal-title":"Arch Dis Child"},{"key":"2021120903270615200_B33","volume-title":"The Management of Sickle Cell Disease. NIH Publication No. 02-2117","author":"National Heart, Lung, and Blood Institute","year":"2002"},{"key":"2021120903270615200_B34","unstructured":"Centers for Disease Control and Prevention. Overweight and obesity. Available at: www.cdc.gov\/obesity\/childhood\/problem.html. Accessed October 19, 2011"},{"issue":"2","key":"2021120903270615200_B35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10900-007-9071-7","article-title":"A multilevel analysis of state and regional disparities in childhood and adolescent obesity in the United States.","volume":"33","author":"Singh","year":"2008","journal-title":"J Community Health"},{"issue":"13","key":"2021120903270615200_B36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199709253371301","article-title":"Predicting obesity in young adulthood from childhood and parental obesity.","volume":"337","author":"Whitaker","year":"1997","journal-title":"N Engl J Med"},{"key":"2021120903270615200_B37"},{"key":"2021120903270615200_B38"},{"issue":"7","key":"2021120903270615200_B39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3324\/haematol.2010.028167","article-title":"Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania.","volume":"96","author":"Cox","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"2021120903270615200_B40","first-page":"361","article-title":"Effect of sickle cell diseases on height and weight.","volume":"27","author":"Helvaci","year":"2011","journal-title":"Pak J Med Sci"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/4\/e1168\/1099651\/peds_2012-2225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/4\/e1168\/1099651\/peds_2012-2225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T18:15:35Z","timestamp":1639073735000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/131\/4\/e1168\/31916\/Weight-Status-of-Children-With-Sickle-Cell-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,1]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2012-2225","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}